Medication info

Hipotens Tablets

Prescription medicationTabletOralExpired
Ingredient · strength
Valsartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 200807059 · Notified 2008.06.25

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults
Adult dose
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg applies when valsartan 160 mg/hydrochlorothiazide 12.5 mg has been prescribed to lower blood pressure. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dosage adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance 30 mL/min or higher). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential Hypertension
View approved original text

This drug helps to effectively manage blood pressure when used additionally in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy.

How to take

Adult dose

○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg applies when valsartan 160 mg/hydrochlorothiazide 12.5 mg has been prescribed to lower blood pressure. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dosage adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance 30 mL/min or higher). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Precautions

This medication may cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, and should be discontinued immediately if pregnancy is confirmed. Patients with allergies to this medication or its components, certain liver diseases, or kidney diseases should not use it. Administration should also be avoided in patients with severely impaired kidney function or certain blood disorders. Since this drug can lower blood pressure, dizziness or symptoms of hypotension may occur upon initial administration, requiring caution. As it can affect potassium levels, potassium supplements should not be taken without consulting a doctor, and regular electrolyte level checks are recommended. During treatment, caution should be exercised while driving or operating machinery, as dizziness may occur. Interactions may arise when used with specific medications, so it is essential to inform healthcare professionals of any other ongoing medications. This drug can rarely cause serious side effects such as skin rash, angioedema, hepatitis, kidney failure, and electrolyte abnormalities, thus any unusual symptoms should be reported to a healthcare provider immediately. Safety in pediatric patients has not been established, so it is recommended not to use it in children. Elderly patients do not have significant differences in effectiveness and side effects from those in younger patients; however, careful monitoring of kidney function and electrolyte status is advised. In the event of overdose, symptoms such as hypotension, arrhythmias, and electrolyte imbalances may occur, necessitating immediate medical attention for appropriate treatment. This medication should be stored in a tightly sealed container to protect it from moisture and to keep it out of reach of children, ideally in its original container for safety.

Side effects

headache, dizziness, nasopharyngitis, fatigue, low back pain, cough, upper respiratory tract infection, diarrhea, arthralgia, abdominal pain, epigastric pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, dyspepsia, dyspnea, erectile dysfunction, enteritis, hyperhidrosis, sensory reduction, insomnia, hypokalemia, hypotension, influenza, muscle cramps, myositis, nausea, nasal congestion, nasal hemorrhage, throat pain, otitis media, limb pain, paresthesia, pharyngodynia, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament sprain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, angioedema, itching, serum sickness, vasculitis, alopecia, renal function impairment, myalgia, anaphylactoid symptoms, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, systemic lupus erythematosus exacerbation, hypoglycemia, rhabdomyolysis, elevated AST, palpitations, hypertriglyceridemia, increased creatine kinase, decreased hemoglobin, thrombocytopenia, increased serum potassium, dizziness, vasculitis, elevated liver function tests, bullous dermatitis, frequency unspecified renal failure, hypokalemia, elevated blood lipids, hyponatremia, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic metabolic alkalosis, hyperglycemia, diabetes mellitus, urticaria, skin rash, photosensitivity reaction, skin lupus erythematosus, decreased appetite, vomiting, abdominal discomfort, constipation, gastrointestinal discomfort, pancreatitis, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmia, sensory loss, sedation, sleep disorders, depression, paresthesia, visual impairment, leukopenia, bone marrow dysfunction, acute respiratory distress syndrome, pneumonia, pulmonary edema, acute renal failure, renal impairment, erythema multiforme, fever, muscle cramps, acute angle-closure glaucoma, nausea, drowsiness, hypovolemia, arrhythmia, muscle stiffness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture and should be kept in a cool place below 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness for a longer duration.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.